The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
To test whether the hypothesis that the Alzheimer's A beta peptide is neurotoxic, we introduced a transgene into mice to direct expression of this peptide to neurons. We show that the transgene is expressed in brain regions which are severely affected in Alzheimer's disease resulting in extensive neuronal degeneration. Morphological and biochemical evidence indicates that the eventual death of these cells occurs by apoptosis. Coincident with the cell degeneration and cell death is the presence of a striking reactive gliosis. Over 50% of the transgenic mice die by 12 months of age, half the normal life span of control mice. These data show that A beta is neurotoxic in vivo and suggest that apoptosis may be responsible for the accompanying neuronal loss, the principal underlying cellular feature of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While evidence for extracellular Aβ deposition was scarce, neuronal Aβ immunoreactivity was detected in the cortex and hippocampus, resulting in abundant neurodegeneration, with biochemical and morphological evidence for an apoptotic mechanism [61].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [61]
In the citing paper
“Efficient secretion of Aβ from the BRI fusion protein distinguishes this approach from studies using Aβ minigene constructs that generate high levels of intracellular Aβ and minimal secreted Aβ (LaFerla et al., 1995).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“However, none of these studies prove or disprove a role of intracellular Aβ in AD pathogenesis.”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“Previous studies with transgenic mice expressing Aβ minigenes that are not efficiently secreted suggest that intracellular Aβ can be neurotoxic (LaFerla et al., 1995), as do studies of direct injection of aggregated Aβ into cultured primary neurons (Zhang et al., 2002).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“lack of plaque formation in intraneuronal Aβ42 accumulating transgenic mice with concomitant neurodegeneration [36, 93] limited conclusions that could be drawn to the human disease, since pathological diagnosis of AD requires Aβ plaques.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [93]
Citations
Cites
1 retracted
Kawabata, S., Higgins, G. A., & Gordon, J. W. (1991) · Nature · doi:10.1038/354476a0 · Cited by 108
RetractedIdentification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Research works printed but not linked: 2
- Wyllie, A.H. Cell death. Int. Rev. Cytol. S17, 755–785 (1987).
- Kim, K.S. et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Comm. 2, 121–130 (1988).
Cited by
Items 301–400 of 511
Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis
Neve, R. L., & McPhie, D. L. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.008 · Cited by 35
Nakai, M., Hojo, K., Yagi, K., Saito, N., Taniguchi, T., Terashima, A., Kawamata, T., Hashimoto, T., Maeda, K., Gschwendt, M., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721179.x · Cited by 33
Jackson, H. M., Onos, K. D., Pepper, K. W., Graham, L. C., Akeson, E. C., Byers, C., Reinholdt, L. G., Frankel, W. N., & Howell, G. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125897 · Cited by 32
Caenorhabditis elegans as a model organism to study APP function
Ewald, C. Y., & Li, C. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2905-7 · Cited by 35
Ancestral State Reconstruction of the Apoptosis Machinery in the Common Ancestor of Eukaryotes
Klim, J., Gładki, A., Kucharczyk, R., Zielenkiewicz, U., & Kaczanowski, S. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200295 · Cited by 33
Secreted Aβ Does Not Mediate Neurotoxicity by Antibody-Stimulated Amyloid Precursor Protein
Sudo, H., Hashimoto, Y., Niikura, T., Shao, Z., Yasukawa, T., Ito, Y., Yamada, M., Hata, M., Hiraki, T., Kawasumi, M., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4604 · Cited by 33
Transgenic and knockout mice in the study of neurodegenerative diseases
Aguzzi, A., Brandner, S., Marino, S., & Steinbach, J. P. (1996) · Journal of Molecular Medicine · doi:10.1007/bf01575443 · Cited by 36
Santiard-Baron, D., Gosset, P., Nicole, A., Sinet, P., Christen, Y., & Ceballos-Picot, I. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7076 · Cited by 35
Making models for Alzheimer's disease
Lamb, B. T. (1995) · Nature Genetics · doi:10.1038/ng0195-4 · Cited by 34
Huang, X., Yee, B. K., Nag, S., Chan, S. T. H., & Tang, F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00242-5 · Cited by 36
Esposito, L., Gan, L., Yu, G., Essrich, C., & Mucke, L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02816.x · Cited by 31
Sun, X., Cole, G. M., Chu, T., Xia, W., Galasko, D., Yamaguchi, H., Tanemura, K., Frautschy, S. A., & Takashima, A. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00265-2 · Cited by 31
EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASE
Giunta, B. N., Deng, J., Jin, J., Sadic, E., Rum, S., Zhou, H., Sanberg, P. R., & Tan, J. (2012) · Technology & Innovation · doi:10.3727/194982412x13378627621752 · Cited by 35
Zheng, J., Watanabe, H., Wines-Samuelson, M., Zhao, H., Gridley, T., Kopan, R., & Shen, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.349738 · Cited by 30
Barucker, C., Bittner, H. J., Chang, P. K. ‐., Cameron, S., Hancock, M. A., Liebsch, F., Hossain, S., Harmeier, A., Shaw, H. S., Charron, F. M., et al. (2015) · Scientific Reports · doi:10.1038/srep15410 · Cited by 33
Araki, W., & Wurtman, R. J. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00050-3 · Cited by 30
Transgenic Mouse Models of Alzheimer's Disease and Amyotrophic Lateral Sclerosis
Borchelt, D., Wong, P. C., Sisodia, S. S., & Price, D. L. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00198.x · Cited by 30
Yaworsky, P. J., Gardner, D. P., & Kappen, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25112 · Cited by 29
Transgenic Animals in Alzheimer's Disease Research
Sturchler, C., & Sommer, B. (1999) · Reviews in the Neurosciences · doi:10.1515/revneuro.1999.10.1.15 · Cited by 33
Caspase-2 is essential for c-Jun transcriptional activation and Bim induction in neuron death
Jean, Y. Y., Ribé, E. M., Pero, M. E., Moskalenko, M., Iqbal, Z., Marks, L. J., Greene, L. A., & Troy, C. M. (2013) · Biochemical Journal · doi:10.1042/bj20130556 · Cited by 29
Zou, C., Kou, R., Gao, Y., Xie, K., & Song, F. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.03.013 · Cited by 28
Alzheimer’s Disease and Neuronal Network Activity
Gleichmann, M., & Mattson, M. P. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8100-3 · Cited by 32
Amyloid β proteins inhibit Cl−‐ATPase activity in cultured rat hippocampal neurons
Yagyu, K., Kitagawa, K., Irie, T., Wu, B., Zeng, X.-T., Hattori, N., & Inagaki, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00446.x · Cited by 28
Rong, X., Sun, Y., Liu, D., Yin, H., Peng, Y., Xu, S., Wang, L., & Wang, X. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12716 · Cited by 30
Effects of lysophosphatidylcholine on β-amyloid-induced neuronal apoptosis
Qin, Z., Zhu, H.-Y., & Hu, Y. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.25 · Cited by 28
Apoptosis in Neurodegenerative Diseases
Nishimoto, I., Okamoto, T., Giambarella, U., & Iwatsubo, T. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61064-9 · Cited by 27
Weber, L. L., Leissring, M. A., Yang, A. J., Glabe, C. G., Cribbs, D. H., & LaFerla, F. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6348 · Cited by 29
Self-citationUnique pharmacological property of ISRIB in inhibition of Aβ-induced neuronal cell death
Hosoi, T., Kakimoto, M., Tanaka, K., Nomura, J., & Ozawa, K. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.08.003 · Cited by 26
No post-genetics era in human disease research
Gusella, J. F., & MacDonald, M. E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg706 · Cited by 30
The Role of Apoptosis in Neurodegenerative Diseases
Desjardins, P., & Ledoux, S. (1998) · Metabolic Brain Disease · doi:10.1023/a:1020605112755 · Cited by 31
Li, L., Xu, D., Lin, J., Zhang, D., Wang, G.-H., Sui, L., Ding, H., & Du, J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.04.014 · Cited by 26
A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes
Heininger, K. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199912)14:8<525::aid-hup140>3.0.co;2-t · Cited by 30
Pepeu, G., Giovannelli, L., Casamenti, F., Cali, C., & Bartolini, L. (1996) · Progress in brain research · doi:10.1016/s0079-6123(08)62111-1 · Cited by 30
Malherbe, P., Richards, J. G., Martin, J. R., Bluethmann, H., Maggio, J. E., & Huber, G. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02070-5 · Cited by 26
Moechars, D., Lorent, K., Dewachter, I., Baekelandt, V., Strooper, B. D., & LEUVEN, F. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00210-6 · Cited by 27
Novel drug development for amyotrophic lateral sclerosis
Hurko, O., & Walsh, F. S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00419-6 · Cited by 33
Interactions of the alzheimer β amyloid fragment (25–35) with peripheral blood dendritic cells
Schmitt, T. L., Steger, M. M., Pavelka, M., & Grubeck-Loebenstein, B. (1997) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(97)01866-6 · Cited by 25
(1998) · Frontiers in neuroscience · doi:10.1201/9781420048490 · Cited by 24
Barrachina, M., Secades, J. J., Lozano, R., Gómez-Santos, C., Ambrosio, S., & Ferrer, I. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03605-3 · Cited by 24
Chronic Stress and Alzheimers Disease-Like Pathogenesis in a Rat Model: Prevention by Nicotine
Alkadhi, K. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376307 · Cited by 23
Nomura, J., Hosoi, T., Kaneko, M., Ozawa, K., Nishi, A., & Nomura, Y. (2016) · Medical Sciences · doi:10.3390/medsci4030014 · Cited by 25
Copper-induced apoptosis and immediate early gene expression in macrophages
Pang, J. S., & Chau, L. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00126-4 · Cited by 23
Rosenblum, W. I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00283-4 · Cited by 27
Homing in on Intracellular Aβ?
Golde, T. E., & Janus, C. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.013 · Cited by 25
Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease
Salazar, A., Osse, A. M. L., Ortiz, A. A., Murtishaw, A. S., & Kinney, J. W. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.10.013 · Cited by 26
Neurogenetic diseases: molecular diagnosis and therapeutic approaches
Müller, U., & Graeber, M. B. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00196782 · Cited by 23
Geriatric epilepsy: Research and clinical directions for the future
Roberson, E. D., Hope, O. A., Martin, R. C., & Schmidt, D. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.04.005 · Cited by 20
The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells
de Paula, C. A. D., Santiago, F. E., Oliveira, A. S., Oliveira, F. A., Almeida, M. C., & Carrettiero, D. C. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0239-x · Cited by 23
Bengtsson, S. K. S., Bäckström, T. C., Brinton, R. D., Irwin, R. W., Johansson, M., Sjöstedt, J., & Wang, M. D. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100206 · Cited by 23
López, E. S., López-Machado, A., Bonilla-Vidal, L., González-Pizarro, R., Silva, A. M., & Souto, E. B. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200218101231 · Cited by 23
Animal models of cognitive dysfunction
Tayebati, S. K. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.026 · Cited by 29
Esler, W. P., Stimson, E. R., Mantyh, P. W., & Maggio, J. E. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09025-4 · Cited by 24
Neurodevelopmental and neurodegenerative hypotheses of schizophrenia: a review and critique
McClure, R. K., & Lieberman, J. A. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200304002-00004 · Cited by 30
Amyloid β and impairment in multiple memory systems in older transgenic APP TgCRND8 mice
Hanna, A., Horne, P., Yager, D., Eckman, C., Eckman, E., & Janus, C. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00510.x · Cited by 20
Protective effects of Liensinine, Isoliensinine, and Neferine on PC12 cells injured by amyloid‐β
Meng, X., Liu, S., Xue, J., Gou, J., Wang, D., Liu, H., Chen, C., & Xu, C. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14303 · Cited by 22
Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach
Navarro, D., Gasparyan, A., Martínez, S. M., Marín, C. D., Navarrete, F., García‐Gutiérrez, M. S., & Manzanares, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087653 · Cited by 21
Alzheimer’s Disease, Drosophila melanogaster and Polyphenols
Jiménez-Del-Río, M., & Velez‐Pardo, C. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_2 · Cited by 24
Transgenic Models of Alzheimer's Disease
Sugarman, M. C., Hinton, S. F., & LaFerla, F. M. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_2 · Cited by 20
Self-citationRegulation of distinct pools of amyloid β-protein by multiple cellular proteases
Leissring, M. A., & Turner, A. J. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt194 · Cited by 21
The amyloid peptide induces early genotoxic damage in human preneuron NT2
Santiard-Baron, D., Lacoste, A., Achard, S., Soulié, C., Nicole, A., Sarasin, A. R., & Ceballos-Picot, I. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00154-3 · Cited by 22
The role of apoptosis in neurodegenerative diseases
Hajimohammadreza, I., & Treherne, J. M. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8861-5_3 · Cited by 22
Amyloid β and Tumorigenesis: Amyloid β-Induced Telomere Dysfunction in Tumor Cells
Qin, H., Wang, J., Ren, J., & Qu, X. (2019) · CCS Chemistry · doi:10.31635/ccschem.019.20180034 · Cited by 19
Hou, J., Cui, J., Yu, L., & Zhang, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.031 · Cited by 19
Velez‐Pardo, C., Jiménez-Del-Río, M., & Lopera, F. J. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00189-x · Cited by 19
Markers of apoptosis and models of programmed cell death in Alzheimer’s disease
Hugon, J., Terro, F., Esclaire, F., & Yardin, C. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_15 · Cited by 20
Increased Serum Levels of CD95 in Alzheimer’s Disease
Richartz, E., Noda, S., Schott, K. J., Günthner, A., Lewczuk, P., & Bartels, M. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000048650 · Cited by 20
Wang, C., Kang, Y., Liu, P., Liu, W., Chen, W., Hayashi, T., Mizuno, K., Hattori, S., Fujisaki, H., & Ikejima, T. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114260 · Cited by 20
Cytosolic amyloid-β peptide 42 escaping from degradation induces cell death
Lee, E. K., Park, Y. W., Shin, D. Y., Mook‐Jung, I., & Yoo, Y. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.166 · Cited by 23
Chaves, E. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-076 · Cited by 19
Control of Apoptosis by Cytokines
May, W. S. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61060-1 · Cited by 20
Aβ Infusion and Related Models of Alzheimer Dementia
Lawlor, P. A., & Young, D. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_17 · Cited by 20
Liu, S., Huang, Z., Zhang, L., Pan, J., Lei, Q., Meng, Y., & Li, Z. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00010 · Cited by 21
Cytotoxic mechanisms by M239V presenilin 2, a little‐analyzed Alzheimer's disease‐causative mutant
Abe, Y., Hashimoto, Y., Tomita, Y., Terashita, K., Aiso, S., Tajima, H., Niikura, T., Matsuoka, M., & Nishimoto, I. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20163 · Cited by 17
Heat shock proteins and their role in human diseases
Tóth, M. E., Gombos, I., & Sántha, M. (2015) · SZTE Publicatio Repozitórium (University of Szeged) · Cited by 25
Transgenic animals as models of neurodegenerative diseases in humans
Theuring, F., Thunecke, M., Kosciessa, U., & Turner, J. D. (1997) · Trends in biotechnology · doi:10.1016/s0167-7799(97)01066-4 · Cited by 18
Alteration of gene expression in Down’s syndrome (DS) brains: its significance in neurodegeneration
Sawa, A. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_30 · Cited by 18
Alzheimer's Disease Research Enters a “New Cycle”: How Significant?
Copani, A., Sortino, M. A., Nicoletti, F., & Stella, A. M. G. (2002) · Neurochemical Research · doi:10.1023/a:1014879311761 · Cited by 16
Chen, X., Li-min, C., Zhu, Y., Fang, F., Yi-can, Z., & Zhao, C. (2003) · PubMed · Cited by 16
Silva, J. C., Shen, Y., Chan, J., Kwan, P., & Jones, N. C. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106994 · Cited by 14
Brain regions and genes affecting myoclonus in animals
Lalonde, R., & Strazielle, C. (2012) · Neuroscience Research · doi:10.1016/j.neures.2012.07.004 · Cited by 13
Experimental and clinical methods in the development of anti‐Alzheimer drugs
Allain, H., Bentué‐Ferrer, D., Zékri, O., Schück, S., Lebreton, S., & Reymann, J. (1998) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1998.tb00919.x · Cited by 16
Role of caspases in neuronal apoptosis
Ventimiglia, R., Lau, L., Kinloch, R. A., Hopkins, A. L., Karran, E. H., Petalidis, L. P., & Ward, R. V. (2001) · Drug Development Research · doi:10.1002/ddr.1155 · Cited by 16
Wong, P. C., Cai, H., Borcheit, D. R., & Price, D. L. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:233 · Cited by 14
GPR12 inhibits migration and promotes apoptosis in esophageal cancer and hypopharyngeal cancer cells
Zhang, M., Yang, X., Chen, S., Jia, W., Ma, X., Wang, J., Qian, Y., Lei, D., Liu, H., & Pan, X. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13933 · Cited by 13
Hsiao, K. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64026-1 · Cited by 13
Neuronal apoptosis as a therapeutic target in neurodegenerative disease
Larner, A. J. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.10.1493 · Cited by 13
Cell cycle progression towards Alzheimer's disease.
Copani, A., Condorelli, F., Canonico, P. L., Nicoletti, F., & Sortino, M. A. (2001) · PubMed · Cited by 12
Effect of Amyloid β- Peptide on Passive Avoidance Learning in Rats: A Behavioral Study
Nikkhah, A., Ghahremanitamadon, F., Zargooshnia, S., Shahidi, ., & Asl, S. S. (2014) · Avicenna Journal of Neuro Psych Physiology · doi:10.17795/ajnpp-18664 · Cited by 14
Saad, Y., Segal, D., & Ayali, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140009 · Cited by 18
The Role of Oxidative Processes and Metal Ions in Aging and Alzheimer’s Disease
Shinobu, L. A., & Beal, M. F. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_13 · Cited by 14
Lü, W., Shu, Y., Zhang, L., Chen, L., Chao, F., Luo, Y., Xiao, Q., Gu, H., Jiang, R., & Tang, Y. C. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314150709 · Cited by 13
Métodos de evaluación de trastornos cognitivos en modelos animales
Rueda, F. N., Pérez‐Ortiz, J. M., Cantó, T. F., Gutiérrez, M. S. G., García‐Payá, E., Leiva-Santana, C., & Manzanares, J. (2008) · Revista de Neurología · doi:10.33588/rn.4703.2008301 · Cited by 22
Wu, B., Kitagawa, K., Yagyu, K., Zhang, N., Hattori, N., & Inagaki, C. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02281-6 · Cited by 11
Fasulo, L., Ugolini, G., Visintin, M., Bradbury, A. M., Verzillo, V., Novák, M., & Cattaneo, A. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82181-8 · Cited by 11
Nasir, J., Theilmann, J., Vaillancourt, J. P., Munday, N. A., Ali, A., Scherer, S. W., Beatty, B., Nicholson, D. W., & Hayden, M. R. (1997) · Mammalian Genome · doi:10.1007/s003359900514 · Cited by 11
Ermekova, K. S., Chang, A., Zambrano, N., de Candia, P., Russo, T., & Sudol, M. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4869-0_10 · Cited by 14
Saleh, B., Srikanth, K. D., Sneh, T., Yue, L., Pelech, S., Elliott, E., & Gil-Henn, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169055 · Cited by 10
An Apoptotic and Endosymbiotic Explanation of the Warburg and the Inverse Warburg Hypotheses
Kaczanowski, S., Klim, J., & Zielenkiewicz, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103100 · Cited by 10
Bonito-Oliva, A., Schedin‐Weiss, S., Younesi, S. S., Tiiman, A., Adura, C., Paknejad, N., Brendel, M., Romin, Y., Parchem, R. J., Graff, C., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14119 · Cited by 12
17β‐estradiol does not protect cerebellar granule cells from excitotoxicity or apoptosis
Miñano-Molina, A. J., Cerbón, M. A., Xifró, X., Malagelada, C., Aguilera, J., & Rodríguez-Álvarez, J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04475.x · Cited by 10
Metadata
- Authors
- LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C., & Jay, G.
- Venue
- Nature Genetics
- Published
- 1995-01
- Volume
- 9
- Issue
- 1
- Pages
- 21-30
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1992484817
- Cited by
- 513
- References
- 69
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 8 · 2020: 11 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 11 · 2015: 16 · 2014: 13 · 2013: 9 · 2012: 13
- FWCI
- 34.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, neurotoxicity, neuronal apoptosis, neurodegeneration, reactive gliosis, transgenic mice, neuronal loss
- MeSH terms
- Alzheimer Disease, Animals, Base Sequence, Gliosis, Humans, Mice, Transgenic, Molecular Sequence Data, Nerve Degeneration, DNA Probes, Gene Expression, Amyloid beta-Peptides, Apoptosis, In Situ Hybridization, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.